3-D Matrix Europe
Self-assembling peptide medical devices for healthcare providers and patients
Highlights
- New on EvolcAdded 2026-11-02
About 3-D Matrix Europe
3-D Matrix Europe develops and commercializes medical devices based on self-assembling peptide technology. Its products include PuraStat and PuraBond haemostatic gels and procedure accessories.
The products are used by healthcare providers to manage bleeding during procedures. The company works with healthcare professionals and a global network of partners and distributors to supply products and support.
The French legal entity was founded in 2012 and is based in Caluire-et-Cuire. The group says its European Central Facility was established in Lyon in 2013; the group is headquartered in Tokyo, Japan.
Product: Medical devices based on self-assembling peptide technology, including haemostatic gels and procedure accessories.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France. From EU award notices (TED) that name 3-D Matrix Europe by its registry number.
- 26 Sep 2024 CHU NANTES · Fourniture de dispositifs médicaux : Pansements / Hémostatiques / Sets de Soins / Nécessaires et Packs de Chirurgie / Casaques Chirurgicales / Orthèses notice
Jobs at 3-D Matrix Europe
Leadership
- Jun Okada · President and Representative DirectorSource: company website
More health & medtech companies
3DCELO
Custom digital dental devices and treatment-planning services for dentists and dental practicesNew on Evolc3DENTAL
Outsourced dental prosthesis manufacturing by laser sintering, 3D printing and milling for dental technicians in FranceYoung companyNew on Evolc3DISC Dental Connect
Intraoral scanners and AI patient-imaging software for dentists and dental clinics in over 70 countriesNew on Evolcaaaep.fr
Online psychometric driving-permit tests and preparation for people seeking to regain suspended, cancelled or invalidated permits in FranceNew on EvolcAb Cube
Pharmacovigilance, clinical trial and oncology data software for pharma sponsors, CROs and cancer centres in EuropeNew on EvolcAckomas
UDI compliance software that helps medical device manufacturers manage and publish regulatory data across databasesYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
- Microsoft ClarityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- HubSpot CMSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
CRM & customer data
- HubSpotMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
